Published in Biopolymers on January 01, 2011
Hydrocarbon-stapled peptides: principles, practice, and progress. J Med Chem (2014) 1.61
Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain. J Am Chem Soc (2011) 1.49
Examining post-translational modification-mediated protein-protein interactions using a chemical proteomics approach. Protein Sci (2013) 0.88
Truncated and helix-constrained peptides with high affinity and specificity for the cFos coiled-coil of AP-1. PLoS One (2013) 0.81
OGlcNAcylation and phosphorylation have similar structural effects in α-helices: post-translational modifications as inducible start and stop signals in α-helices, with greater structural effects on threonine modification. Biochemistry (2014) 0.80
Small molecule probes to target the human Mediator complex. Isr J Chem (2013) 0.76
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell (1998) 9.96
Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science (1996) 9.48
Transcription regulation and animal diversity. Nature (2003) 9.22
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12
Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov (2004) 7.84
Transcription factors as targets for cancer therapy. Nat Rev Cancer (2002) 7.27
Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature (2007) 6.26
Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell (1997) 5.39
Direct inhibition of the NOTCH transcription factor complex. Nature (2009) 4.82
Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell (2006) 4.28
beta-Peptides: from structure to function. Chem Rev (2001) 4.14
Recognition of the DNA minor groove by pyrrole-imidazole polyamides. Curr Opin Struct Biol (2003) 3.80
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell (2004) 3.43
Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat Rev Cancer (2003) 2.88
Foldamers as versatile frameworks for the design and evolution of function. Nat Chem Biol (2007) 2.79
Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide. J Am Chem Soc (2007) 2.71
Strategies for targeting protein-protein interactions with synthetic agents. Angew Chem Int Ed Engl (2005) 2.65
Drug discovery with engineered zinc-finger proteins. Nat Rev Drug Discov (2003) 2.63
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc Natl Acad Sci U S A (2004) 2.25
Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr Biol (1997) 2.25
Helical beta-peptide inhibitors of the p53-hDM2 interaction. J Am Chem Soc (2004) 2.15
Beta-peptidic peptidomimetics. Acc Chem Res (2008) 2.01
Inhibiting transcription of chromosomal DNA with antigene peptide nucleic acids. Nat Chem Biol (2005) 2.00
Contemporary strategies for the stabilization of peptides in the alpha-helical conformation. Curr Opin Chem Biol (2008) 1.99
Foldamers with heterogeneous backbones. Acc Chem Res (2008) 1.96
Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers. Proc Natl Acad Sci U S A (2009) 1.87
Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface. ACS Chem Biol (2007) 1.84
Short constrained peptides that inhibit HIV-1 entry. Proc Natl Acad Sci U S A (2002) 1.77
A complex task? Direct modulation of transcription factors with small molecules. Curr Opin Chem Biol (2010) 1.75
The triple helix: 50 years later, the outcome. Nucleic Acids Res (2008) 1.73
Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions. J Am Chem Soc (2009) 1.72
Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. FASEB J (2000) 1.69
Targeting protein-protein interactions: lessons from p53/MDM2. Biopolymers (2007) 1.67
A hydrogen bond surrogate approach for stabilization of short peptide sequences in alpha-helical conformation. Acc Chem Res (2008) 1.67
Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism. Proc Natl Acad Sci U S A (1997) 1.61
Enhanced metabolic stability and protein-binding properties of artificial alpha helices derived from a hydrogen-bond surrogate: application to Bcl-xL. Angew Chem Int Ed Engl (2005) 1.59
Completion of a Programmable DNA-Binding Small Molecule Library. Tetrahedron (2007) 1.58
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions. Proc Natl Acad Sci U S A (2003) 1.54
Inhibition of transcription factors with small organic molecules. Curr Opin Chem Biol (2008) 1.51
Terphenyl-based helical mimetics that disrupt the p53/HDM2 interaction. Angew Chem Int Ed Engl (2005) 1.49
Disrupting protein-protein interactions with non-peptidic, small molecule alpha-helix mimetics. Curr Opin Chem Biol (2010) 1.47
Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism. J Biol Chem (2009) 1.44
Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate alpha-helix. J Am Chem Soc (2010) 1.42
Downsizing human, bacterial, and viral proteins to short water-stable alpha helices that maintain biological potency. Proc Natl Acad Sci U S A (2010) 1.38
Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression. Proc Natl Acad Sci U S A (2009) 1.38
Assessment of helical interfaces in protein-protein interactions. Mol Biosyst (2009) 1.37
Helices and other secondary structures of beta- and gamma-peptides. Biopolymers (2006) 1.35
Design and synthesis of alpha-helical peptides and mimetics. Org Biomol Chem (2007) 1.35
Peptide nucleic acid: a versatile tool in genetic diagnostics and molecular biology. Curr Opin Biotechnol (2001) 1.34
Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. Angew Chem Int Ed Engl (2007) 1.34
Inhibition of HIV-1 fusion by hydrogen-bond-surrogate-based alpha helices. Angew Chem Int Ed Engl (2008) 1.32
Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides. Proc Natl Acad Sci U S A (2000) 1.32
Exploring beta-sheet structure and interactions with chemical model systems. Acc Chem Res (2008) 1.31
Systematic analysis of helical protein interfaces reveals targets for synthetic inhibitors. ACS Chem Biol (2010) 1.29
A TAD further: exogenous control of gene activation. ACS Chem Biol (2007) 1.27
The synthesis and study of side-chain lactam-bridged peptides. Biopolymers (2002) 1.27
Oligobenzamide proteomimetic inhibitors of the p53-hDM2 protein-protein interaction. Chem Commun (Camb) (2009) 1.24
beta-Peptides as inhibitors of protein-protein interactions. Bioorg Med Chem (2005) 1.24
A rapid library screen for tailoring beta-peptide structure and function. J Am Chem Soc (2005) 1.24
Peptoid architectures: elaboration, actuation, and application. Curr Opin Chem Biol (2008) 1.24
Synthesis, biological activity and conformational analysis of cyclic GRF analogs. Int J Pept Protein Res (1988) 1.18
Using a beta-hairpin to mimic an alpha-helix: cyclic peptidomimetic inhibitors of the p53-HDM2 protein-protein interaction. Angew Chem Int Ed Engl (2004) 1.16
Direct inhibition of hypoxia-inducible transcription factor complex with designed dimeric epidithiodiketopiperazine. J Am Chem Soc (2009) 1.15
Efficient synthesis of a beta-peptide combinatorial library with microwave irradiation. J Am Chem Soc (2005) 1.13
Miniature protein inhibitors of the p53-hDM2 interaction. Chembiochem (2006) 1.11
Turning a scorpion toxin into an antitumor miniprotein. J Am Chem Soc (2008) 1.10
Small molecule modulators of transcription. Angew Chem Int Ed Engl (2006) 1.10
Design of novel sequence-specific DNA-binding proteins. Curr Opin Chem Biol (2000) 1.07
Transcriptional switches: chemical approaches to gene regulation. J Biol Chem (2010) 1.02
Modular alpha-helical mimetics with antiviral activity against respiratory syncitial virus. J Am Chem Soc (2006) 1.02
Novel selective inhibitors of the interaction of individual nuclear hormone receptors with a mutually shared steroid receptor coactivator 2. J Am Chem Soc (2003) 1.02
Molecular recognition of protein surfaces: high affinity ligands for the CBP KIX domain. J Am Chem Soc (2003) 1.01
An alpha-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction. J Am Chem Soc (2006) 1.00
Nucleation and stability of hydrogen-bond surrogate-based alpha-helices. Org Biomol Chem (2006) 0.99
Synthesis of constrained helical peptides by thioether ligation: application to analogs of gp41. Chem Commun (Camb) (2005) 0.97
Crystallographic analysis of an 8-mer p53 peptide analogue complexed with MDM2. J Am Chem Soc (2006) 0.96
Apamin as a template for structure-based rational design of potent peptide activators of p53. Angew Chem Int Ed Engl (2009) 0.95
Cell-permeable beta-peptide inhibitors of p53/hDM2 complexation. Chembiochem (2009) 0.95
Solid phase synthesis of hydrogen bond surrogate derived alpha-helices: resolving the case of a difficult amide coupling. Org Biomol Chem (2010) 0.94
Notch signaling as a therapeutic target. Curr Opin Chem Biol (2002) 0.93
Alpha-turn mimetics: short peptide alpha-helices composed of cyclic metallopentapeptide modules. J Am Chem Soc (2004) 0.92
Binding mode and transcriptional activation potential of high affinity ligands for the CBP KIX domain. J Am Chem Soc (2005) 0.91
Coordinated control of the gene expression machinery. Trends Genet (2010) 0.89
Peptides as protein binding site mimetics. Curr Opin Chem Biol (2008) 0.86
Regulating transcription: a chemical perspective. Org Biomol Chem (2003) 0.82
Contemporary strategies for the stabilization of peptides in the alpha-helical conformation. Curr Opin Chem Biol (2008) 1.99
An orthosteric inhibitor of the Ras-Sos interaction. Nat Chem Biol (2011) 1.91
Arresting cancer proliferation by small-molecule gene regulation. Chem Biol (2004) 1.90
A hydrogen bond surrogate approach for stabilization of short peptide sequences in alpha-helical conformation. Acc Chem Res (2008) 1.67
Enhanced metabolic stability and protein-binding properties of artificial alpha helices derived from a hydrogen-bond surrogate: application to Bcl-xL. Angew Chem Int Ed Engl (2005) 1.59
A highly stable short alpha-helix constrained by a main-chain hydrogen-bond surrogate. J Am Chem Soc (2004) 1.58
Cellular uptake of N-methylpyrrole/N-methylimidazole polyamide-dye conjugates. Bioorg Med Chem (2002) 1.52
Evaluation of biologically relevant short alpha-helices stabilized by a main-chain hydrogen-bond surrogate. J Am Chem Soc (2006) 1.47
Assessing helical protein interfaces for inhibitor design. J Am Chem Soc (2011) 1.46
Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate alpha-helix. J Am Chem Soc (2010) 1.42
Assessment of helical interfaces in protein-protein interactions. Mol Biosyst (2009) 1.37
Inhibition of HIV-1 fusion by hydrogen-bond-surrogate-based alpha helices. Angew Chem Int Ed Engl (2008) 1.32
Systematic analysis of helical protein interfaces reveals targets for synthetic inhibitors. ACS Chem Biol (2010) 1.29
High specificity in protein recognition by hydrogen-bond-surrogate α-helices: selective inhibition of the p53/MDM2 complex. Chembiochem (2010) 1.19
Solid-phase synthesis of hydrogen-bond surrogate-derived alpha-helices. Org Lett (2005) 1.19
Nonpeptidic foldamers from amino acids: synthesis and characterization of 1,3-substituted triazole oligomers. J Am Chem Soc (2005) 1.13
Atomic structure of a short alpha-helix stabilized by a main chain hydrogen-bond surrogate. J Am Chem Soc (2008) 1.11
Solid-phase synthesis of short α-helices stabilized by the hydrogen bond surrogate approach. Nat Protoc (2010) 1.07
Optimized synthesis of hydrogen-bond surrogate helices: surprising effects of microwave heating on the activity of Grubbs catalysts. Org Lett (2006) 1.06
Oligooxopiperazines as nonpeptidic alpha-helix mimetics. Org Lett (2010) 1.05
Plucking the high hanging fruit: a systematic approach for targeting protein-protein interactions. Bioorg Med Chem (2012) 1.03
Nucleation and stability of hydrogen-bond surrogate-based alpha-helices. Org Biomol Chem (2006) 0.99
Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling. Proc Natl Acad Sci U S A (2013) 0.96
Solid phase synthesis of hydrogen bond surrogate derived alpha-helices: resolving the case of a difficult amide coupling. Org Biomol Chem (2010) 0.94
Adding diverse noncanonical backbones to rosetta: enabling peptidomimetic design. PLoS One (2013) 0.94
Trapping a folding intermediate of the alpha-helix: stabilization of the pi-helix. Biochemistry (2008) 0.93
Anatomy of β-strands at protein-protein interfaces. ACS Chem Biol (2014) 0.89
Solution- and solid-phase synthesis of triazole oligomers that display protein-like functionality. J Org Chem (2007) 0.88
Rational design of topographical helix mimics as potent inhibitors of protein-protein interactions. J Am Chem Soc (2014) 0.87
Design, synthesis and protein-targeting properties of thioether-linked hydrogen bond surrogate helices. Chem Commun (Camb) (2011) 0.87
Chemical biology: A Notch above other inhibitors. Nature (2009) 0.87
Nucleation effects in peptide foldamers. J Am Chem Soc (2012) 0.86
Evaluation of triazolamers as active site inhibitors of HIV-1 protease. Bioorg Med Chem Lett (2009) 0.86
Chromatin structure determines accessibility of a hairpin polyamide-chlorambucil conjugate at histone H4 genes in pancreatic cancer cells. Bioorg Med Chem Lett (2012) 0.82
HippDB: a database of readily targeted helical protein-protein interactions. Bioinformatics (2013) 0.82
Effects of side chains in helix nucleation differ from helix propagation. Proc Natl Acad Sci U S A (2014) 0.82
Cross-dressing proteins by olefin metathesis. Nat Chem Biol (2008) 0.81
Reversible α-helix formation controlled by a hydrogen bond surrogate. Tetrahedron (2011) 0.80
Profiling small molecule inhibitors against helix-receptor interactions: the Bcl-2 family inhibitor BH3I-1 potently inhibits p53/hDM2. Chem Commun (Camb) (2010) 0.79
A ribozyme with michaelase activity: synthesis of the substrate precursors. Bioorg Med Chem (2003) 0.78
Making strides in peptide-based therapeutics. Chem Biol (2009) 0.77
Synthesis of hydrogen-bond surrogate α-helices as inhibitors of protein-protein interactions. Curr Protoc Chem Biol (2014) 0.77
End-Capped α-Helices as Modulators of Protein Function. Drug Discov Today Technol (2012) 0.77
Dynamical binding of hydrogen-bond surrogate derived Bak helices to antiapoptotic protein Bcl-xL. J Phys Chem B (2009) 0.76
Reversible redox reconfiguration of secondary structures in a designed peptide. Angew Chem Int Ed Engl (2012) 0.76
Side-Chain Conformational Preferences Govern Protein-Protein Interactions. J Am Chem Soc (2016) 0.75
Guest-accelerated molecular rotor. Org Lett (2010) 0.75
Correction to Inhibition of Hypoxia Inducible Factor 1-Transcription Coactivator Interaction by a Hydrogen Bond Surrogate α-Helix. J Am Chem Soc (2012) 0.75
A small molecule diacid with long-term chiral memory. Org Lett (2009) 0.75